Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.630
0.000
Volume:- -
Turnover:- -
Market Cap:1.63B
PE:-5.53
High:2.630
Open:2.630
Low:2.630
Close:2.630
52wk High:5.830
52wk Low:2.300
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.475
ROE:-242.61%
ROA:-18.75%
PB:-103.14
PE(LYR):-5.53
PS:- -

Loading ...

Biopharma Stocks Rally as Sector Gains Strategic "Emerging Pillar" Status

Stock News
·
Mar 06

National Committee Member Ding Lieming Advocates for Enhanced Medical Insurance Fund Support

Deep News
·
Mar 05

CMS Pharmaceutical's Innovative siRNA Drug CMS-D008 Receives Clinical Trial Approval for Overweight/Obesity Indication

Stock News
·
Mar 04

Innovative Drug Sector Shows Partial Recovery with Yahong Meditech Surging 20%

Deep News
·
Mar 04

Immunotech Biopharm (06978) Announces February 2026 Monthly Return

Bulletin Express
·
Mar 03

Beijing Aosaikang Pharmaceutical's Innovative Drug Maltol Iron Capsule Receives Acceptance for Marketing Authorization Application

Stock News
·
Mar 02

Beijing Hotgen Biotech Announces First Patient Dosed in Phase Ib Trial of Innovative Drug AA001 for Alzheimer's Disease

Stock News
·
Mar 02

China Securities: Chinese Pharmaceutical Firms Hold Engineering Edge, Advise Focus on Asthma and COPD Innovation Leaders

Stock News
·
Mar 02

SINO BIOPHARM's Self-Developed Innovative Drug Rovaxicitinib Approved for Market Launch

Stock News
·
Mar 02

Jingxin Pharma's Dual Financial Strategy Raises Questions as It Pursues A+H Listing

Deep News
·
Feb 28

Biokin Reports Over 1 Billion Yuan Loss as Innovation Drug Leader's Transformation Journey Continues

Deep News
·
Feb 28

Biotech Leader Achieves First Annual Profit, Signaling Harvest Phase

Deep News
·
Feb 27

Xuguan Aims for 55 Billion Yuan Total Output with Three-Year Plan for Emerging Industries

Deep News
·
Feb 27

Hong Kong Stock Connect Biotech Sector Declines, ETF 520880 Drops Over 1% Amid Wide Premium

Deep News
·
Feb 26

Immunotech Biopharm Invests 50 Million Yuan in Structured Deposit Product

MT Newswires Live
·
Feb 26

BRIEF-Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN

Reuters
·
Feb 25

IMMUNOTECH-B Allocates 50 Million Yuan to Structured Deposit from Shanghai Pudong Development Bank

Stock News
·
Feb 25

Immunotech Biopharm - Subscribed to Structured Deposit Product With Investment Value of RMB50 Mln

THOMSON REUTERS
·
Feb 25

Frontier Biotechnologies, a Sub-¥8 Billion Market Cap Biopharma, Plummets to Become A-Shares' Biggest Loser

Deep News
·
Feb 25

CMS Receives NMPA Acceptance and Priority Review for Ruxolitinib Cream's Atopic Dermatitis Application

Stock News
·
Feb 24